R. Ortmann

1.8k total citations
43 papers, 1.4k citations indexed

About

R. Ortmann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, R. Ortmann has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in R. Ortmann's work include Neurotransmitter Receptor Influence on Behavior (14 papers), Receptor Mechanisms and Signaling (9 papers) and Neuroscience and Neuropharmacology Research (8 papers). R. Ortmann is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (14 papers), Receptor Mechanisms and Signaling (9 papers) and Neuroscience and Neuropharmacology Research (8 papers). R. Ortmann collaborates with scholars based in Switzerland, Germany and United States. R. Ortmann's co-authors include Hans Grisebach, A. Delini‐Stula, Arne Sutter, Serge Bischoff, P. C. Waldmeier, Klaus Hahlbrock, Eckard Wellmann, John P. Perkins, P. Spreyer and Denis Monard and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

R. Ortmann

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Ortmann Switzerland 21 720 621 222 204 103 43 1.4k
Peter F. T. Vaughan United Kingdom 27 1.3k 1.9× 902 1.5× 158 0.7× 422 2.1× 63 0.6× 89 2.0k
Porntip Supavilai Thailand 24 844 1.2× 1.0k 1.6× 106 0.5× 100 0.5× 123 1.2× 43 1.5k
Kazuo Kawasaki Japan 18 560 0.8× 515 0.8× 124 0.6× 310 1.5× 128 1.2× 51 1.2k
S W Rogers United States 11 1.3k 1.8× 523 0.8× 188 0.8× 145 0.7× 43 0.4× 15 1.7k
Jiro Itoh Japan 19 695 1.0× 539 0.9× 366 1.6× 161 0.8× 156 1.5× 36 1.5k
Bernard Schmidt Germany 25 754 1.0× 687 1.1× 462 2.1× 337 1.7× 304 3.0× 77 1.7k
Sándor L. Erdö Hungary 24 623 0.9× 997 1.6× 79 0.4× 330 1.6× 84 0.8× 68 1.7k
Roy D. Schwarz United States 21 819 1.1× 566 0.9× 186 0.8× 336 1.6× 115 1.1× 58 1.4k
Richard A. Keith United States 23 1.1k 1.6× 650 1.0× 134 0.6× 399 2.0× 75 0.7× 54 1.9k
Stuart J. Mickel Switzerland 16 1.2k 1.6× 1.1k 1.8× 109 0.5× 130 0.6× 148 1.4× 33 2.1k

Countries citing papers authored by R. Ortmann

Since Specialization
Citations

This map shows the geographic impact of R. Ortmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ortmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ortmann more than expected).

Fields of papers citing papers by R. Ortmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ortmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ortmann. The network helps show where R. Ortmann may publish in the future.

Co-authorship network of co-authors of R. Ortmann

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ortmann. A scholar is included among the top collaborators of R. Ortmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ortmann. R. Ortmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wießner, Christoph, Karl‐Heinz Wiederhold, Alain C. Tissot, et al.. (2011). The Second-Generation Active A  Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects. Journal of Neuroscience. 31(25). 9323–9331. 149 indexed citations
2.
Staufenbiel, Matthias, Karl‐Heinz Wiederhold, Alain C. Tissot, et al.. (2006). O1–06–01: Immunization with Aβ1–6 coupled to the virus–like particle Qβ (CAD106) efficiently removes β–amyloid without inducing Aβ–reactive T–cells. Alzheimer s & Dementia. 2(3S_Part_1). 2 indexed citations
3.
Storch, Alexander, R. Ortmann, Andreas Hein, et al.. (2002). Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson’s disease: studies using heterologous expression systems of the dopamine transporter. Biochemical Pharmacology. 63(5). 909–920. 72 indexed citations
4.
Asselbergs, Fred A.M., R. Ortmann, Bastian Hengerer, et al.. (1998). Position-independent expression of a human nerve growth factor-luciferase reporter gene cloned on a yeast artificial chromosome vector. Nucleic Acids Research. 26(7). 1826–1833. 4 indexed citations
5.
Naumann, T., et al.. (1994). Is there a long-lasting effect of a short-term nerve growth factor application on axotomized rat septohippocampal neurons?. Neuroscience Letters. 173(1-2). 213–215. 25 indexed citations
6.
Spreyer, P., et al.. (1989). Induction of glia-derived nexin after lesion of a peripheral nerve. Nature. 342(6249). 548–550. 102 indexed citations
7.
Olpe, H.-R., K. Klebs, A. Glatt, et al.. (1987). Cholinomimetics induce θ rhythm and reduce hippocampal pyramidal cell excitability. European Journal of Pharmacology. 142(2). 275–283. 31 indexed citations
8.
Ortmann, R., et al.. (1986). Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.. PubMed. 36(12). 1727–32. 1 indexed citations
9.
Ortmann, R. & D. Woermann. (1986). Properties of Bariumsulfate Precipitation Membranes: Study of Current-Voltage Curves. Zeitschrift für Physikalische Chemie. 148(2). 231–245. 8 indexed citations
10.
Ortmann, R., et al.. (1985). Precipitation zones with membrane properties in gels. Journal of Colloid and Interface Science. 104(1). 136–142. 3 indexed citations
11.
Waldmeier, P. C., P. A. Baumann, H. Bittiger, et al.. (1984). CGP 15 210 G, AN UNUSUAL INHIBITOR OF SEROTONIN (5-HT) UPTAKE. Clinical Neuropharmacology. 7. S472–S472. 1 indexed citations
12.
Ortmann, R., et al.. (1982). Correlations between different measures of antiserotonin activity of drugs. Naunyn-Schmiedeberg s Archives of Pharmacology. 321(4). 265–270. 91 indexed citations
13.
14.
Ortmann, R., et al.. (1981). Interaction of ?-adrenoceptor agonists with the serotonergic system in rat brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 316(3). 225–230. 53 indexed citations
15.
Cubeddu, L., et al.. (1976). Regulation of adenosine 3':5'-monophosphate content of human astrocytoma cells: mechanism of agonist-specific desensitization.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(4). 271–85. 26 indexed citations
16.
Clark, R B, Y F Su, R. Ortmann, et al.. (1975). Factors influencing the effect of hormones on the accumulation of cyclic AMP in cultured human astrocytoma cells. Metabolism. 24(3). 343–358. 47 indexed citations
17.
Sutter, Arne, R. Ortmann, & Hans Grisebach. (1972). Purification and properties of an enzyme from cell suspension cultures of parsley catalyzing the transfer of d-glucose from UDP-d-glucose to flavonoids. Biochimica et Biophysica Acta (BBA) - Enzymology. 258(1). 71–87. 48 indexed citations
18.
Hahlbrock, Klaus, Jürgen Ebel, R. Ortmann, et al.. (1971). Regulation of enzyme activities related to the biosynthesis of flavone glycosides in cell suspension culture of parsley (Petroselinum hortense). Biochimica et Biophysica Acta (BBA) - General Subjects. 244(1). 7–15. 120 indexed citations
19.
Hahlbrock, Klaus, Arne Sutter, Eckard Wellmann, R. Ortmann, & Hans Grisebach. (1971). Relationship between organ development and activity of enzymes involved in flavone glycoside biosynthesis in young parsley plants. Phytochemistry. 10(1). 109–116. 46 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter F. T. Vaughan Breakdown of academic impact, for papers by Porntip Supavilai Breakdown of academic impact, for papers by Kazuo Kawasaki Breakdown of academic impact, for papers by S W Rogers Breakdown of academic impact, for papers by Jiro Itoh Breakdown of academic impact, for papers by Bernard Schmidt Breakdown of academic impact, for papers by Sándor L. Erdö Breakdown of academic impact, for papers by Roy D. Schwarz Breakdown of academic impact, for papers by Richard A. Keith Breakdown of academic impact, for papers by Stuart J. Mickel
Rankless by CCL
2026